%0 Journal Article %T Aspirin versus placebo in pregnancies at high risk for preterm pre-eclampsia %A Catherine Nelson-Piercy %A Lisa Story %J Archive of "Obstetric Medicine". %D 2018 %R 10.1177/1753495X18775898 %X A recent multicentre placebo-controlled trial by Rolnick et al. has indicated that taking 150 mg aspirin daily in women at high risk of pre-eclampsia reduced the incidence of the disease from 4.3% to 1.5% in comparison with placebo. Although the findings of this study are important, a high proportion of women withdrew their consent and not all safety outcomes have been reported. This journal watch article discusses the paper in more detail %K Aspirin %K pre-eclampsia %U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038012/